Full Length Research Paper
References
|
Alledrone G, Pollastro F, Magagini G, Taglialatela-scafati O, Seegers J, Koeberle A, Werz O, Appendino G (2017). The bibenzyl canniprene inhibits the production of pro-inflammatory eicosanoids and selectively accumulates in some Cannabis sativa strains. Journal of Natural Products 80(3):731-734. |
|
|
Andre CM, Hausman JF, Guerriero G (2016). Cannabis sativa: The plant of the Thousand and one molecules. Frontiers in Plant Science 7(19):1-17. |
|
|
Basavarajappa BS (2017). Chapter 2 - Cannabinoid Receptors and their Signaling Mechanisms. In: Rodríguez EM, The Endocannabinoid System. Genetics, Biochemistry, Brain Disorders, and Therapy. pp. 25-62. |
|
|
Beale C, Broyd SJ, Chye Y, Suo C, Schira M, Galettis P, Martin JH, Yuce M, Solowiji N (2018). Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users. Cannabis and Cannabinoid Research 3(1):94-107. |
|
|
Begg M, Pacher P, Batkai S, Osei-hyiaman D, Offertáler L, Mo FM, Liu J, Kunos (2005). Evidence of new cannabinoid receptors. Pharmacology and Therapeutics 106(2):133-145. |
|
|
Crippa JA, Guimarães FS, Campos AC, Zuardi AW (2018). Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a New Age. Frontiers of Immunology, 9:2009. |
|
|
Hua T, Vemuri K, Pu M, Qu L, Han GW, Wu Y, Zhao S, Shui W, Li S, Korde A, Laprairie RB, Stahl E, Ho JH, Zvonok N, Zhou H, Kufareva I, Wu B, Zhao Q, Hanson MA, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ (2016). Crystal structure of the Human Cannabinoid Receptor CB1. Cell 167(3):750-762. |
|
|
Jiang R, Yamaori S, Okamoto Y, Yamamoto I, Watanabe K (2013). Cannabidiol is a potent inhibitor of the Catalytic Activity of Cytochrome P4502C19. Drug Metabolism and Pharmacokinetics 28(4):332-338. |
|
|
Kumar KK, Shalev-benami M, Robertson M, Hu H, Banister SD, Hollingsworth SA, Latorraca NR, Kato HE, Hilger D, Maeda S, Weis WI, Farrens DL, Dror RO, Malhotra SV, Kobilka BK, Skiniotis G (2019). Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex. Cell 176(3):448-458. |
|
|
Lorenzen E, Sakmar TP (2019). Receptor Structures for a Caldron of Cannabinoids. Cell 176(3):409-411. |
|
|
Maroon J, Bost J (2018). Review of the neurological benefits of phytocannabinoids. Surgical Neurology International 9:91. |
|
|
Massi P, Solinas M, Cinquina V, Parolaro D (2013.) Cannabidiol as potential anticancer drug. British Journal of Clinical Pharmacology 75(2):303-312. |
|
|
Matsuda LA, Lolait SJ, Brownsten M, Young AC, Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of cloned cDNA. Nature 346:561-564. |
|
|
Muller C, Morales P, Reggio PH (2019). Cannabinoid Ligands Targeting TRP Channels. Frontiers in Molecular Neuroscience 11:487. |
|
|
Munro S, Thomas KL, Abu-shaar M (1993). Molecular characterization of a peripheral cannabinoid receptor. Nature 365(6441):61-65. |
|
|
Pertwee RG (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: ∆9-tetrahydrocannabinol, cannabidiol and ∆9 -tetrahydrocannabivarin. British Journal of Pharmacology 153(2):199-215. |
|
|
Perucca E (2017). Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? Journal of Epilepsy Research 7(2):60-76. |
|
|
Pellati F, Brighenti V, Sperlea JI, Marchetti L, Bertelli D, Benvenutri S (2018). New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp). Molecules 23(10):2639. |
|
|
Pollastro F, Minassi A, Fresu LG 2018. Cannabis phenolics and their bioactivities. Current Medicinal Chemistry 25(10):1160-1185. |
|
|
Romero-Sandoval EA, Fincham JE, Kolano AL, Sharpe BN, Alvarado-Vázquez PA (2018). Cannabis for Chronic Pain: Challenges and Considerations. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38(6):651-662. |
|
|
Wertz O, Seegers J, Schaible AM, Barz D, Koeberle A, Allegroned G, Pollastro F, Zampieri L, Grassi G, Appendino G (2014). Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. Pharma Nutrition 2(3):53-60. |
|
|
Whittermore R, Knafl K (2005). The integrative review: updated methodology. Journal of Clinical Nursing 52(5):546-553. |
|
|
Zendulka O, Dovrtelová G, Nosková K, Turjap M, Sulcová A, Hanus L, Jurica J. (2016). Cannabinoids and Cytochrome P450 Interactions. Current Drug Metabolism 17(3):206-226. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
